{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:49:11Z","timestamp":1790920151232,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.bbrc.2008.07.012","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T15:40:48Z","timestamp":1216136448000},"page":"309-314","source":"Crossref","is-referenced-by-count":29,"title":["HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway"],"prefix":"10.1016","volume":"374","author":[{"given":"Dominik","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Berges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Opelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord","family":"Naujokat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2008.07.012_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"Friesen","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggert","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2008.07.012_bib3","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bbapap.2006.09.017","article-title":"Hydrophobic modifications of Ras proteins by isoprenoid groups and fatty acids\u2014more than just membrane anchoring","volume":"1764","author":"Pechlivanis","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2008.07.012_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2008.07.012_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2008.07.012_bib7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1124\/jpet.107.132217","article-title":"Inhibition of geranylgerany diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes","volume":"324","author":"Dudakovic","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2008.07.012_bib8","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1073\/pnas.0305149101","article-title":"Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lyphoblastoid cell lines and delays development of EBV lymphomas","volume":"101","author":"Katano","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.07.012_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0609.2007.00902.x","article-title":"First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma","volume":"79","author":"Schmidmaier","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.LAB.0000022226.23741.37","article-title":"Role and function of the 26S proteasome in proliferation and apoptosis","volume":"82","author":"Naujokat","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2008.07.012_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jcb.21405","article-title":"Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells","volume":"103","author":"Fuchs","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2008.07.012_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1074-5521(01)00069-2","article-title":"Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic \u03b2-subunit","volume":"8","author":"Kessler","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib13","first-page":"5735","article-title":"Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells","volume":"9","author":"van de Donk","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2008.07.012_bib14","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/1535-7163.MCT-06-0745","article-title":"Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma","volume":"6","author":"Wong","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2008.07.012_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CMR.0b013e3282f60097","article-title":"Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells","volume":"18","author":"Saito","year":"2008","journal-title":"Melanoma Res."},{"key":"10.1016\/j.bbrc.2008.07.012_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/MCB.18.1.629","article-title":"Effects of p21Cip1\/Waf1 at both the G1\/S and the G2\/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication","volume":"18","author":"Niculescu","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib17","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood-2003-03-0970","article-title":"Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels","volume":"102","author":"van de Donk","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2008.07.012_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood-2003-12-4218","article-title":"The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase","volume":"104","author":"Schmidmaier","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2008.07.012_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bcp.2007.10.010","article-title":"Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-\u03baB pathway","volume":"75","author":"Ahn","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1242\/jcs.01118","article-title":"Rho-family GTPases: it\u00b4s not only Rac and Rho (and I like it)","volume":"117","author":"Wennerberg","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2008.07.012_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0955-0674(03)00098-X","article-title":"Role of Rho-family proteins in cell adhesion and cancer","volume":"15","author":"Malliri","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2008.07.012_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymthe.2004.08.029","article-title":"Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo","volume":"11","author":"Pill\u00e9","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2008.07.012_bib23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/sj.cdd.4401873","article-title":"RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42\/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation","volume":"13","author":"Fromigu\u00e9","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2008.07.012_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2007.11.002","article-title":"Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylase inhibitor in HeLa cells","volume":"365","author":"Gan","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2008.07.012_bib25","unstructured":"C. Riganti, S. Doubler, C. Costamagna, E. Alfieri, G. Pescarmona, D. Ghigo, A. Bosia, Activation of NF-\u03baB pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells, Mol Pharmacol., in press."},{"key":"10.1016\/j.bbrc.2008.07.012_bib26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1101\/gad.1326205","article-title":"BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis","volume":"19","author":"G\u00e9linas","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2008.07.012_bib27","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.07.012_bib28","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1182\/blood-2004-10-3984","article-title":"Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis","volume":"105","author":"Nencioni","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2008.07.012_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08013429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08013429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T07:50:43Z","timestamp":1545897043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X08013429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0006291X08013429"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.012","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}